At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
prophylactic injection therapyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Prophylactic Injection Therapy Reduces Recurrent Bleeding Rate In Forrest Type IIb Duodenal Ulcer Bleeding
Bakirkoy Dr. Sadi Konuk Research and Training Hospital·interventional·Posted Nov 15, 2011·Updated Nov 15, 2011
In Brief
A clinical study evaluating prophylactic injection therapy for Duodenal Ulcer Bleeding. Completed, enrolled 80 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether prophylactic injection therapy reduces recurrent bleeding rate for duodenal ulcers which has the endoscopic stigmata of recent bleeding.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDuodenal Ulcer Bleeding
CountriesTurkey (Türkiye)
Collaborators--
Timeline
N/ACompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2003
Primary CompletionOct 2009
First PostedNov 2011
TodayJul 2026
First PostedNov 15, 2011
Enrollment StartJan 1, 2003
Primary CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 6.8 yearsPosted 14.6 years ago
Interventions
prophylactic injection therapyprocedure
Standard application of endoscopic injection therapy as it is used for actively bleeding ulcers, 10 ml of serum saline with 1/10000 epinephrine is submucosally injected to the four quadrants of the ulcer margins.